Translate Your Bacteriophage Therapies into Market-Ready Products by Navigating Regulatory Frameworks, Scaling GMP Manufacturing & Delivering Clinically Proven, Precision-Engineered Solutions Across Human & Non-Human Health
This is the only industry-led, industry dedicated meeting, tackling the real-world challenges preventing bacteriophage therapies from reaching patients – from manufacturing and clinical trial design to investment models and evolving regulatory expectations. As regulators clarify approval pathways, phage’s make it into late-stage clinical trials, and investment momentum returns, 2026 marks a pivotal moment for the phage field to shift from promise to practical delivery.
If you are determined to ensure the community can bring precise, scalable and commercially viable products to market, this is your one-stop platform to make it happen.
Over three days, you will connect directly with C-level experts, decision-makers and leading minds across biotech, pharma, academia, policy and investment who are defining how phage-based products move through approval and adoption. Discover new data, actionable frameworks and the collaborations that will shape the next generation of antibacterial solutions.
Join us to help translate phage science into sustainable, patient-ready therapies and position yourself at the centre of this fast-maturing field.
This conference is invaluable to the phage community as it is dedicated to phage therapy but with a focus on how to get products in the market in order to serve a large amount of patients.
Speaker, Chief Scientific Officer, Technophage
Attending a Bacteriophage Conference is an exciting opportunity for anyone passionate about microbiology, infectious diseases, or biotechnology. Conferences such as these could transform how we understand and harness bacteriophages. Beyond the science, it’s a chance to engage with a vibrant, global community united by curiosity, creativity, and the potential of phage and phage-based approaches to revolutionize medicine and microbiology.
Speaker, Chief Executive Officer, Telum Therapeutics
Phage conferences like this bring together the science, the commercialization strategy, and the shared purpose of building a real global field, not just isolated efforts. I’m looking forward to conversations that bridge lab and clinical results to community delivery. I’m eager to discuss how we actually get phage drugs to the people who need them.
Speaker, Chief Executive Officer & Co-Founder, Phagepro
Full Event Guide
- 18+ Speakers, bringing you critical insights from key companies including Armata Therapeutics, Technophage, SNIPR Biome and more
- 80% C-Suite or Equivalent Speakers, ensuring you are gaining the freshest data and optimized clinical trial strategies, powering your pipeline with the expertise of others
- 18 Case Studies, spanning investment, regulation, manufacturing and other critical industry
- 10 Networking hours, ensuring you have time to connect and discuss with leaders from the field, and ensuring you are a part of the conversation as the future of phages is dictated
- 3 Panel Discussions, giving you opportunities to hear open and honest opinions from phage developers, manufacturers, policy shapers and academics – and chance for you to ask any burning questions
Attending Companies Include
Explore Related Events
Explore the Agenda
Hear the latest breakthroughs driving bacteriophage therapies to patients and gain practical insights through data-driven talks, panels and roundtables.
Partner With Us
Position your brand at the centre of the phage ecosystem and connect with companies shaping the future of antibacterial innovation.
Join Biopharma Experts
Be part of the global phage community advancing research, regulation and commercialisation while making valuable connections across every stage of development.